These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 18394338)
1. [Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells]. Tu SF; Guo KY; Hu LS; Mei JZ; Zhou J; Sun M Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):341-3, 347. PubMed ID: 18394338 [TBL] [Abstract][Full Text] [Related]
2. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells]. Mei JZ; Guo KY; Wei HM; Song CY Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663 [TBL] [Abstract][Full Text] [Related]
3. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis]. Guo KY; Mei JZ; Yao KT Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963 [TBL] [Abstract][Full Text] [Related]
4. Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Ebihara T; Masuda H; Akazawa T; Shingai M; Kikuta H; Ariga T; Matsumoto M; Seya T Int Immunol; 2007 Oct; 19(10):1145-55. PubMed ID: 17878262 [TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of NKG2D ligands in 13 tumor cell lines]. Wang YP; Zhang C; Niu JF; Zhang JH; Xu XQ; Wang JF Ai Zheng; 2008 Mar; 27(3):243-8. PubMed ID: 18334111 [TBL] [Abstract][Full Text] [Related]
6. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression. Song H; Kim J; Cosman D; Choi I Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway. Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340 [TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645 [TBL] [Abstract][Full Text] [Related]
9. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484 [TBL] [Abstract][Full Text] [Related]
10. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. Eleme K; Taner SB; Onfelt B; Collinson LM; McCann FE; Chalupny NJ; Cosman D; Hopkins C; Magee AI; Davis DM J Exp Med; 2004 Apr; 199(7):1005-10. PubMed ID: 15051759 [TBL] [Abstract][Full Text] [Related]
11. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318 [TBL] [Abstract][Full Text] [Related]
12. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Welte SA; Sinzger C; Lutz SZ; Singh-Jasuja H; Sampaio KL; Eknigk U; Rammensee HG; Steinle A Eur J Immunol; 2003 Jan; 33(1):194-203. PubMed ID: 12594848 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate. Chávez-Blanco A; De la Cruz-Hernández E; Domínguez GI; Rodríguez-Cortez O; Alatorre B; Pérez-Cárdenas E; Chacón-Salinas R; Trejo-Becerril C; Taja-Chayeb L; Trujillo JE; Contreras-Paredes A; Dueñas-González A Int J Oncol; 2011 Dec; 39(6):1491-9. PubMed ID: 21805029 [TBL] [Abstract][Full Text] [Related]
14. The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells. Zhang B; Wei H; Zheng X; Zhang J; Sun R; Tian Z Peptides; 2005 Mar; 26(3):405-12. PubMed ID: 15652646 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands. Schulz U; Kreutz M; Multhoff G; Stoelcker B; Köhler M; Andreesen R; Holler E Scand J Immunol; 2010 Oct; 72(4):319-31. PubMed ID: 20883317 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. Ostberg JR; Dayanc BE; Yuan M; Oflazoglu E; Repasky EA J Leukoc Biol; 2007 Nov; 82(5):1322-31. PubMed ID: 17711975 [TBL] [Abstract][Full Text] [Related]
17. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. López-Soto A; Folgueras AR; Seto E; Gonzalez S Oncogene; 2009 Jun; 28(25):2370-82. PubMed ID: 19430493 [TBL] [Abstract][Full Text] [Related]
18. Four novel ULBP splice variants are ligands for human NKG2D. Cao W; Xi X; Wang Z; Dong L; Hao Z; Cui L; Ma C; He W Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572 [TBL] [Abstract][Full Text] [Related]
20. Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy. Park MJ; Bae JH; Chung JS; Kim SH; Kang CD Immunol Invest; 2011; 40(4):367-82. PubMed ID: 21314289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]